News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
3d
MedPage Today on MSNFDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other VaccinesThe unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
49m
Scripps News on MSNHHS, NIH announce development of universal vaccine for COVID-19 and influenzaResearchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.
Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...
CBS News - Video on MSN1d
What's holding up new COVID booster guidance from the FDAThe Food and Drug Administration was set to release new guidance on COVID booster shots ahead of the fall season, but that's ...
The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results